Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis Ltd in Biomarkers
- Vol. 12 (5), 484-496
- https://doi.org/10.1080/13547500701421341
Abstract
An objective assessment of exposure to tobacco smoke may be accomplished by means of examining particular biomarkers in body fluids. The most common biomarker of tobacco smoke exposure is urinary, or serum, cotinine. In order to distinguish non-smokers from passive smokers and passive smokers from active smokers, it is necessary to estimate cotinine cut-off points. The objective of this article was to apply statistical distribution of urinary cotinine concentration to estimate cut-off points distinguishing the three above-mentioned groups. The examined group consisted of 327 volunteers (187 women and 140 men) who were ethnically homogenous inhabitants of the same urban agglomeration (Sosnowiec, Poland). The values which enabled differentiation of the examined population into groups and subgroups were as follows: 50 µg l−1 (differentiation of non-smokers from passive smokers), 170 µg l−1 (to divide the group of passive smokers into two subgroups: minimally and highly exposed to environmental tobacco smoke), 550 µg l−1 (differentiation of passive smokers from active smokers), and 2100 µg l−1 (to divide group of active smokers into two subgroups: minimally and highly exposed to tobacco smoke). The results suggest that statistical distribution of urinary cotinine concentration is useful for estimating urinary cotinine cut-off points and for assessing the smoking status of persons exposed to tobacco smoke.Keywords
This publication has 27 references indexed in Scilit:
- CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum SmokingCancer Epidemiology, Biomarkers & Prevention, 2006
- Serum Cotinine Level as Predictor of Lung Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2006
- Smoking Topography, Brand Switching, and Nicotine Delivery: Results from an In vivo StudyCancer Epidemiology, Biomarkers & Prevention, 2005
- Assessment of smoking status in patients with peripheral arterial diseaseJournal of Vascular Surgery, 2005
- German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German populationInternational Journal of Hygiene and Environmental Health, 2003
- Clinical considerations in study designs that use cotinine as a biomarkerBiomarkers, 2003
- Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolismBritish Journal of Clinical Pharmacology, 2002
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Urinary cotinine levels of smokeless tobacco (MaraE powder) users1Human & Experimental Toxicology, 2000
- Measurement of Current Exposure to Environmental Tobacco SmokeArchives of environmental health, 1990